Luc Thomas
Prof Luc Thomas is an expert in Dermatology at Centre Hospitalier Lyon Sud (France). As of October 2026, ScienceLeadR ranks Luc Thomas in the top 1% of experts worldwide for Skin Neoplasms and Melanoma. Luc Thomas has authored 409 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 1,253 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Oncology - Public Health - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 409
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Expanding Skin Cancer Detection: A Training Program With Tele-Dermoscopy Support for Physiotherapists. PMID 42581028 — skin, physical therapists, education, medical, melanoma, neoplasms, dermatology, skin neoplasms, dermoscopy | Int J Dermatol | 2026 | 0 |
| Unexpected remission of Darier disease in a melanoma patient treated with trametinib and naporafenib. PMID 42388280 — melanoma, darier disease | JAAD Case Rep | 2026 | 1 |
| Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings. PMID 42234423 — skin, intelligence, neoplasms, multiple chronic conditions, skin diseases, algorithms, physicians, foundations, diagnosis, artificial intelligence, skin neoplasms | JAMA Dermatol | 2026 | 0 |
| Characterizing Longitudinal Melanonychia in Skin of Color. PMID 42160087 — skin, skin diseases | JAMA Dermatol | 2026 | 0 |
| Improving GP dermoscopy training through nosological performance analysis. PMID 42059833 — sexually transmitted diseases, general practitioners, education, medical, skin diseases, dermoscopy | J Eur Acad Dermatol Venereol | 2026 | 0 |
Clinical Studies 18
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients NCT05029791 — cells, cell plasticity, blood, melanoma, neoplasms, biopsy, therapeutics, edetic acid | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map